SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-007219
Filing Date
2023-06-05
Accepted
2023-06-05 07:05:27
Documents
57
Period of Report
2023-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-060523.htm   iXBRL 8-K 32818
2 PRESS RELEASE OF THE COMPANY, JUNE 5, 2023 ex99-01.htm EX-99.01 26783
3 TNX 601 ER & TNX-4300: MAJOR DEPRESSIVE DISORDER ex99-02.htm EX-99.02 75868
4 A RANDOMIZED PLACEBO-CONTROLLED MULTICENTER TRIAL OF MONOTHERAPY WITH TNX-601 ER ex99-03.htm EX-99.03 1572
8 GRAPHIC ex99-02_image01.jpg GRAPHIC 159176
9 GRAPHIC ex99-02_image02.jpg GRAPHIC 245210
10 GRAPHIC ex99-02_image03.jpg GRAPHIC 164519
11 GRAPHIC ex99-02_image04.jpg GRAPHIC 169843
12 GRAPHIC ex99-02_image05.jpg GRAPHIC 178415
13 GRAPHIC ex99-02_image06.jpg GRAPHIC 244747
14 GRAPHIC ex99-02_image07.jpg GRAPHIC 194120
15 GRAPHIC ex99-02_image08.jpg GRAPHIC 170278
16 GRAPHIC ex99-02_image09.jpg GRAPHIC 194609
17 GRAPHIC ex99-02_image10.jpg GRAPHIC 176636
18 GRAPHIC ex99-02_image11.jpg GRAPHIC 138167
19 GRAPHIC ex99-02_image12.jpg GRAPHIC 189094
20 GRAPHIC ex99-02_image13.jpg GRAPHIC 185318
21 GRAPHIC ex99-02_image14.jpg GRAPHIC 202439
22 GRAPHIC ex99-02_image15.jpg GRAPHIC 151288
23 GRAPHIC ex99-02_image16.jpg GRAPHIC 117462
24 GRAPHIC ex99-02_image17.jpg GRAPHIC 153887
25 GRAPHIC ex99-02_image18.jpg GRAPHIC 179298
26 GRAPHIC ex99-02_image19.jpg GRAPHIC 179160
27 GRAPHIC ex99-02_image20.jpg GRAPHIC 177411
28 GRAPHIC ex99-02_image21.jpg GRAPHIC 194756
29 GRAPHIC ex99-02_image22.jpg GRAPHIC 216415
30 GRAPHIC ex99-02_image23.jpg GRAPHIC 116100
31 GRAPHIC ex99-02_image24.jpg GRAPHIC 189652
32 GRAPHIC ex99-02_image25.jpg GRAPHIC 212223
33 GRAPHIC ex99-02_image26.jpg GRAPHIC 171321
34 GRAPHIC ex99-02_image27.jpg GRAPHIC 167052
35 GRAPHIC ex99-02_image28.jpg GRAPHIC 178699
36 GRAPHIC ex99-02_image29.jpg GRAPHIC 254215
37 GRAPHIC ex99-02_image30.jpg GRAPHIC 128062
38 GRAPHIC ex99-02_image31.jpg GRAPHIC 200448
39 GRAPHIC ex99-02_image32.jpg GRAPHIC 136688
40 GRAPHIC ex99-02_image33.jpg GRAPHIC 177439
41 GRAPHIC ex99-02_image34.jpg GRAPHIC 201552
42 GRAPHIC ex99-02_image35.jpg GRAPHIC 190831
43 GRAPHIC ex99-02_image36.jpg GRAPHIC 164557
44 GRAPHIC ex99-02_image37.jpg GRAPHIC 184945
45 GRAPHIC ex99-02_image38.jpg GRAPHIC 227094
46 GRAPHIC ex99-02_image39.jpg GRAPHIC 147574
47 GRAPHIC ex99-02_image40.jpg GRAPHIC 195451
48 GRAPHIC ex99-02_image41.jpg GRAPHIC 150615
49 GRAPHIC ex99-03_image01.jpg GRAPHIC 10343754
  Complete submission text file 0001387131-23-007219.txt   24752100

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20230605.xsd EX-101.SCH 2968
6 XBRL LABEL FILE tnxp-20230605_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE tnxp-20230605_pre.xml EX-101.PRE 22365
51 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-060523_htm.xml XML 3467
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 23991209
SIC: 2834 Pharmaceutical Preparations